CG Oncology, Inc. Common stock
CG Oncology, Inc. Common stock（CGON）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cgon · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$93.00
Consensus
$82.57
+53.7% upside
Low
$70.00
Median: $82 · Last Close: $53.72
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$82.57
53.7% upside
High Target
$93
73.1%
Low Target
$70
30.3%
Current Price
$53.72
as of today
Based on analyst price targets, the CGON stock price prediction for the next 12 months ranges from $70 to $93. The consensus CGON price forecast of $82.57 implies 53.7% upside from the current price of $53.72.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $51.03 | ↓ 5.00% |
1-day model range: $50.75–$51.32. Peak: $51.32 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $56 | +5.0% |
| 2028 | $58 | +8.2% |
| 2029 | $59 | +10.2% |
| 2030 | $60 | +11.4% |
| 2031 | — | +12.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CGON · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-11 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-11 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-11 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-27 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-17 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CG Oncology, Inc. Common stock (CGON) stock. Of the recent 45 rating actions, 2 were upgrades and 0 were downgrades. 10 analysts currently cover CGON.
分析师推荐趋势
CGON analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 6 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$11M
↓ 97.6% YoY
Revenue Next Year
$87M
↑ 689.4% YoY
EPS This Year
$-2.74
EPS Next Year
$-2.84
↑ 3.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CGON EPS of $-2.74 for the current fiscal year, based on estimates from 12 analysts. The CGON revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CGON 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CGON 的共识目标价为 $82.57（+53.7% 上行空间），分析师共识为 Buy。
CGON 的短期预测（明日）为 $51.03（-5.00%）。 CGON 对 2027 年的股价预测均值为 $56。 CGON 对 2030 年的预测区间为 $56–$63。
CG Oncology, Inc. Common stock 在 NASDAQ 上市，代码 CGON。CGON 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CGON 预测 · 8 个问题根据 10 位华尔街分析师，CGON 的 12 个月平均目标价为 $82.57，最高 $93.00、最低 $70.00。若有图表，中位目标价可在上方查看。相对当前价 $53.72，隐含约 +53.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.